Zobrazeno 1 - 10 of 366 pro vyhledávání: '"E. Bermingham"'
2
Considerations for extrapolating in vivo bioequivalence data across species and routes
Autor: E. Bermingham, C. Lainesse, S. Modric, C. Thompson, M. Heit
Publikováno v: Journal of Veterinary Pharmacology and Therapeutics. 35:45-52
The purpose of this article is to discuss the numerous species-specific and route-specific factors that can influence the peak and extent of exposure of an active pharmaceutical ingredient as they relate to the demonstration of bioequivalence between
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::422dcb44b01db57c4a3f756cc06a042a
https://doi.org/10.1111/j.1365-2885.2012.01365.x
Zobrazit plný text záznamu
3
Demonstrating bioequivalence using clinical endpoint studies
Autor: C. Lainesse, E. Bermingham, Kirby Pasloske, S. V. Radecki, J.R.E. del Castillo
Publikováno v: Journal of Veterinary Pharmacology and Therapeutics. 35:31-37
For drug products not amenable to blood level studies, clinical endpoint studies have been used as an indirect measure of formulation difference in bioavailability between test and reference products. However, clinical endpoint studies are not as sen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29ec9c820f465b1fe07a8872c34d7755
https://doi.org/10.1111/j.1365-2885.2012.01366.x
Zobrazit plný text záznamu
4
What is a Wood-Warbler? Molecular Characterization of a Monophyletic Parulidae
Autor: I. J. Lovette, E. Bermingham
Publikováno v: The Auk. 119:695-714
The wood-warblers (family Parulidae) fall within a radiation of passerine birds commonly known as the New World nine-primaried oscines. Defining familial relationships within that radiation has previously been challenging because of its extremely hig
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::705e74dc10ccbef6760c501397b325be
https://doi.org/10.1093/auk/119.3.695
Zobrazit plný text záznamu
6
Demonstrating bioequivalence using clinical endpoint studies
Autor: E, Bermingham, J R E, Del Castillo, C, Lainesse, K, Pasloske, S, Radecki
Publikováno v: Journal of veterinary pharmacology and therapeutics. 35
For drug products not amenable to blood level studies, clinical endpoint studies have been used as an indirect measure of formulation difference in bioavailability between test and reference products. However, clinical endpoint studies are not as sen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9f6d56510bd3815a5447fc31f104193f
https://pubmed.ncbi.nlm.nih.gov/22413789
Zobrazit plný text záznamu
7
Considerations for extrapolating in vivo bioequivalence data across species and routes
Autor: S, Modric, E, Bermingham, M, Heit, C, Lainesse, C, Thompson
Publikováno v: Journal of veterinary pharmacology and therapeutics. 35
The purpose of this article is to discuss the numerous species-specific and route-specific factors that can influence the peak and extent of exposure of an active pharmaceutical ingredient as they relate to the demonstration of bioequivalence between
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7f07dc1d0ab5c83088b15bb9c321f022
https://pubmed.ncbi.nlm.nih.gov/22413791
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje